07:00 , Mar 24, 2008 |  BioCentury  |  Finance

Nomura's investments

Nomura's investments...
07:00 , May 23, 2005 |  BioCentury  |  Finance

U.S. investment in Europe

U.S. investment in Europe...
08:00 , Mar 20, 2000 |  BioCentury  |  Finance

Waiting for the verdict

All eyes will be on Celltech as the London Stock Exchange opens for business on Monday, the first day it will trade as a FTSE 100 company. The LSE was closed when an FDA advisory...
08:00 , Jan 4, 2000 |  BC Week In Review  |  Company News

Tissuemed board of directors update

Tissuemed Ltd., Leeds, U.K.   Business: Biomaterial/Skin/Wound   Appointed: Laurie Rostron, former general partner at Alta Berkeley Associates, as a non-executive director   Resigned: Christopher Crabtree as a non-executive director  ...
07:00 , Sep 7, 1999 |  BioCentury  |  Finance

Just a little off the top, please

After jacking up as high as $19 intraday on Friday,...
07:00 , Oct 20, 1997 |  BioCentury  |  Finance

European private rounds

European private rounds...
07:00 , Aug 11, 1997 |  BioCentury  |  Strategy

SmithKline spins out its orphan assets

Noteworthy There is a growing realization among the major pharmaceutical companies that even with billion-dollar R&D budgets there always will be research projects that cannot be provided with adequate resources. Moreover, the increasing pressure to...